Selection of Biologics in Severe Asthma: A Multifaceted Algorithm

被引：12
作者：
Davila, I [1 ,2 ,3 ]
Quirce, S. [4 ,5 ]
Olaguibel, J. M. [5 ,6 ]
机构：
[1] Hosp Univ Salamanca, Salamanca, Spain
[2] Univ Salamanca, Inst Biomed Res Salamanca, Fac Med, Dept Biomed & Diagnost Sci, Salamanca, Spain
[3] RETIC ARADyAL, Madrid, Spain
[4] Hosp La Paz Inst Hlth Res IdIPAZ, Dept Allergy, Madrid, Spain
[5] CIBER Resp Dis CIBERES, Madrid, Spain
[6] Complejo Hosp Navarra, Severe Asthma Unit, Pamplona, Spain
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2019年 / 29卷 / 04期
关键词：
Severe asthma; Algorithm; Biologics; OMALIZUMAB;
D O I：
10.18176/jiaci.0398
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：325 / 328
页数：4
相关论文
共 15 条
  • [1] Predicting and evaluating response to omalizumab in patients with severe allergic asthma
    Bousquet, J.
    Rabe, K.
    Humbert, M.
    Chung, K. F.
    Berger, W.
    Fox, H.
    Ayre, G.
    Chen, H.
    Thomas, K.
    Blogg, M.
    Holgate, S.
    [J]. RESPIRATORY MEDICINE, 2007, 101 (07) : 1483 - 1492
  • [2] Care pathways for the selection of a biologic in severe asthma
    Bousquet, Jean
    Brusselle, Guy
    Buhl, Roland
    Busse, William W.
    Cruz, Alvaro A.
    Djukanovic, Ratko
    Domingo, Christian
    Hanania, Nicola A.
    Humbert, Marc
    Gow, Andrew Menzies
    Phipatanakul, Wanda
    Wahn, Ulrich
    Wechsler, Michael E.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (06)
  • [3] Busse William W, 2019, Allergol Int, V68, P158, DOI 10.1016/j.alit.2019.01.004
  • [4] Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma
    Casale, T. B.
    Chipps, B. E.
    Rosen, K.
    Trzaskoma, B.
    Haselkorn, T.
    Omachi, T. A.
    Greenberg, S.
    Hanania, N. A.
    [J]. ALLERGY, 2018, 73 (02) : 490 - 497
  • [5] Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J.
    Wenzel, S.
    Rabe, K. F.
    Busse, W. W.
    Ford, L.
    Sher, L.
    FitzGerald, J. M.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M. H.
    Hamilton, J. D.
    Swanson, B. N.
    Stahl, N.
    Yancopoulos, G. D.
    Teper, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26) : 2486 - 2496
  • [6] Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]
  • [7] International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
    Chung, Kian Fan
    Wenzel, Sally E.
    Brozek, Jan L.
    Bush, Andrew
    Castro, Mario
    Sterk, Peter J.
    Adcock, Ian M.
    Bateman, Eric D.
    Bel, Elisabeth H.
    Bleecker, Eugene R.
    Boulet, Louis-Philippe
    Brightling, Christopher
    Chanez, Pascal
    Dahlen, Sven-Erik
    Djukanovic, Ratko
    Frey, Urs
    Gaga, Mina
    Gibson, Peter
    Hamid, Qutayba
    Jajour, Nizar N.
    Mauad, Thais
    Sorkness, Ronald L.
    Teague, W. Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (02) : 343 - 373
  • [8] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
    Gonzalez I, Davila
    Benitez F, Moreno
    Quirce, S.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 84 - 93
  • [9] Severe and Difficult-to-Treat Asthma in Adults
    Israel, Elliot
    Reddel, Helen K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (10) : 965 - 976
  • [10] Moral VP, 2016, J INVEST ALLERG CLIN, V26, P1, DOI 10.18176/jiaci.0065
12